The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 12, 2019

Filed:

Sep. 19, 2014
Applicants:

National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki-shi, Osaka, JP;

Daiichi Sankyo Company, Limited, Tokyo, JP;

Inventors:

Ken Ishii, Ibaraki, JP;

Kouji Kobiyama, Ibaraki, JP;

Taiki Aoshi, Ibaraki, JP;

Fumihiko Takeshita, Tokyo, JP;

Yuji Kasuya, Tokyo, JP;

Takako Niwa, Tokyo, JP;

Makoto Koizumi, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01); A61K 39/39 (2006.01); C07H 21/04 (2006.01); C08B 37/00 (2006.01); A61K 31/713 (2006.01); A61K 39/145 (2006.01); A61K 39/155 (2006.01); C12N 15/117 (2010.01); A61K 31/7125 (2006.01);
U.S. Cl.
CPC ...
C12N 15/117 (2013.01); A61K 31/713 (2013.01); A61K 31/7125 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/155 (2013.01); A61K 39/39 (2013.01); C07H 21/04 (2013.01); C08B 37/0024 (2013.01); C12N 7/00 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55583 (2013.01); C12N 2310/17 (2013.01); C12N 2310/315 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3519 (2013.01); C12N 2320/31 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/18534 (2013.01);
Abstract

The present invention provides an oligodeoxynucleotide containing humanized K type CpG oligodeoxynucleotide and poly deoxyadenylate, wherein the poly deoxyadenylate is placed on the 3'-side of the humanized K type CpG oligodeoxynucleotide. In addition, the present invention provides a complex containing the aforementioned oligodeoxynucleotide and β-1,3-glucan.


Find Patent Forward Citations

Loading…